Sekisui

Sekisui Contract Manufacturing & Development (CDMO) Profile

BioProduction by Sekisui is a biologics CDMO focused on microbial fermentation and purification. Our UK facility has over 40 years of microbial expression experience. We offer expertise in bioprocess development, scale up and manufacturing of enzymes, plasmids, antibody fragments and other high purity proteins. We are in the process of a $19M expansion of our cGMP facility for drug substance manufacturing which will complete in 2024.

CDMO Services:
Biologics Analytical Development; Cell Line Development; Formulation Development; ICH Stability Testing; Process Development; Protein Synthesis Antibodies; Antibody-drug conjugate (ADC); Recombinants + other Proteins; Protein Vaccines; Plasmid DNA

Year Founded: 2011

Head Office: FRAMINGHAM, United States

Number of Facilities: 1-2

Facility locations: Europe

Website: Visit the Sekisui website

Linkedin: Connect on Linkedin

Current Capacity: We have availability in our GMP microbial facility in 2025.